ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dinh Xuan, A.
Right arrow Articles by Lockhart, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dinh Xuan, A.
Right arrow Articles by Lockhart, A
Eur Respir J 1989; 2: 409-414
Copyright © ERS Journals Ltd 1989


Clinical Trial

Pretreatment with an inhaled alpha 1-adrenergic agonist, methoxamine, reduces exercise-induced asthma

AT Dinh Xuan, M Chaussain, J Regnard, and A Lockhart

In order to assess the role of the bronchial circulation in the pathogenesis of exercise-induced asthma (EIA), we conducted a double-blind, randomized study of the effects of pretreatment with an inhaled alpha 1-adrenergic agonist, methoxamine (Mx), in nine asthmatic teenagers with known EIA. Exercise consisted of 5 min cycle ergometry at a submaximal, constant work-load, while the subjects breathed dry air at ambient temperature. Forced expiratory volume in one second (FEV1) was measured at baseline, 15 min after pretreatment of either Mx or saline, and serially after exercise. Mx significantly reduced the exercise-induced fall of FEV1 without modifying baseline FEV1 in five of the eight subjects, had little or no effect in three and caused an acute asthmatic attack in the remaining subject. Mx has potent constrictor effects on both bronchial and vascular smooth muscles through stimulation of postjunctional alpha 1-adrenoceptors. Therefore, the protective effect of Mx on EIA may be attributed to vasoconstriction of tracheobronchial vessels opposing the hyperaemia and mucosal airway oedema that may cause, at least in part, the exercise-induced acute bronchial obstruction in EIA. Alternatively, Mx stimulates mucus, water and electrolyte secretion by airway epithelium and may, therefore, oppose the dehydration of airway surface that could be a causative factor of EIA.


This article has been cited by other articles:


Home page
Toxicol PatholHome page
C. J. Smith, D. W. Bombick, B. A. Ryan, M. J. Morton, and D. J. Doolittle
Pulmonary Function in Nonsmokers Following Exposure to Sidestream Cigarette Smoke
Toxicol Pathol, February 1, 2001; 29(2): 260 - 264.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
A. N. Freed, S. McCulloch, and Y. Wang
Eicosanoid and muscarinic receptor blockade abolishes hyperventilation-induced bronchoconstriction
J Appl Physiol, November 1, 2000; 89(5): 1949 - 1955.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. N. Freed, V. Taskar, B. Schofield, and C. Omori
Hyperventilation-induced airway injury and vascular leakage in dogs: effects of alpha 1-adrenergic agonists
J Appl Physiol, December 1, 1997; 83(6): 1884 - 1889.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the European Respiratory Society.